A promising drug combination could help people with leukemia who don't respond to traditional treatments, according to new research. A team at Oregon Health and Science University made the discovery ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
As part of the first-in-human trial, participants received more than 15 times the standard dose of the chemotherapy drug doxorubicin every 21 days for up to one year. “Usually, a patient can only ...
May 14 (Reuters) - The U.S. Food and Drug Administration has approved AbbVie's (ABBV.N), opens new tab drug to treat adults with a type of lung cancer who have received previous treatment, the ...
When a drug is injected directly into a tumour, macrophages already present in the body absorb the drug and begin producing ...
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...
The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the Broad Institute that treats non-small cell lung cancer — the most common type ...
Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...
Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down. Researchers are now unraveling how these medications affect immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback